Cyclo Therapeutics
Cyclo Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for rare and neurodegenerative diseases. The company specializes in the use of cyclodextrin-based drug candidates, targeting conditions such as Niemann-Pick Disease Type C and Alzheimer’s disease. Through its proprietary technology and commitment to advancing patient care, Cyclo Therapeutics aims to address significant unmet medical needs. The company’s research and development efforts are supported by a robust pipeline and collaborations with leading scientific partners. Cyclo Therapeutics is dedicated to improving health outcomes by delivering novel treatment options that have the potential to transform the lives of patients and their families.
